Novo's new insulin pen allows finer-scale adjustments

08/21/2013 | Drug Store News

Novo Nordisk received federal approval for its NovoPen Echo insulin pen, which enables half-unit dosing. The smaller doses allow for more precise adjustments, particularly helpful for treating children with diabetes. The device, the first of its kind in the U.S., also features a memory function that keeps track of dose and time frame between shots.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR